30.09.2014 • News • chemicals • Pharmaceuticals • Merck

Moody Reviews German Merck’s Credit Rating

The US credit ratings agency Moody's has said it is reviewing the credit rating of German chemicals and pharmaceuticals producer Merck KGaA in connection with the company's plans to acquire laboratory products specialist Sigma-Aldrich.

Merck currently has a rating of A3.

Moody's said that while the acquisition makes sense strategically, the purchase price of over €13 billion would more than triple the Darmstadt-based company's debt burden to more than €17 billion.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.